Esperion Therapeutics Inc (ESPR)
2.13
-0.12
(-5.33%)
USD |
NASDAQ |
May 24, 16:00
2.18
+0.05
(+2.35%)
After-Hours: 20:00
Esperion Therapeutics Gross Profit (TTM): 188.05M for March 31, 2024
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 188.05M |
December 31, 2023 | 73.07M |
September 30, 2023 | 66.93M |
June 30, 2023 | 58.81M |
March 31, 2023 | 49.47M |
December 31, 2022 | 48.51M |
September 30, 2022 | 44.18M |
June 30, 2022 | 40.55M |
March 31, 2022 | 69.75M |
Date | Value |
---|---|
December 31, 2021 | 64.23M |
September 30, 2021 | 61.85M |
June 30, 2021 | 56.56M |
March 31, 2021 | 229.54M |
December 31, 2020 | 225.16M |
September 30, 2020 | 218.19M |
June 30, 2020 | 215.61M |
March 31, 2020 | 4.754M |
December 31, 2019 | 148.36M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
4.754M
Minimum
Mar 2020
229.54M
Maximum
Mar 2021
103.53M
Average
65.58M
Median
Gross Profit (TTM) Benchmarks
United Therapeutics Corp | 2.220B |
Dynavax Technologies Corp | 189.73M |
Heron Therapeutics Inc | 75.40M |
Aldeyra Therapeutics Inc | -- |
Deciphera Pharmaceuticals Inc | 169.58M |